Staphylococcus aureus MQCL 113 is an aerobe, Gram-positive, coccus-shaped human pathogen that has multiple antibiotic resistances.
antibiotic resistance Gram-positive coccus-shaped aerobe human pathogen Bacteria| @ref 20215 |
Last LPSN update
2026-05-29 08:30:25 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 18923 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 18923 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 41602 | MEDIUM 72- for trypto casein soja agar | Distilled water make up to (1000.000 ml);Trypto casein soy agar (40.000 g) | |||
| 116616 | CIP Medium 72 | Medium recipe at CIP |
| 63395 | Oxygen toleranceaerobe |
| Test 1 | Test 2 | Test 3 | Test 4 | |
|---|---|---|---|---|
| @ref | 18923 | 18923 | 18923 | 18923 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Müller-Hinton Agar |
| Manual annotation | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 20 | 20 | 22 | 20-22 |
| Ampicillin 10µg (disc) | 14 | 16 | 16 | 12 |
| Aztreonam 30µg (disc) | 0 | 0 | 0 | 0 |
| Bacitracin 10Unit | 16-18 | 18 | 18 | n.d. |
| Cefalotin 30µg (disc) | 32 | 32 | 32 | n.d. |
| Cefazolin 30µg (disc) | 28 | 28 | 28 | n.d. |
| Cefiderocol 30µg (disc) | n.d. | n.d. | n.d. | 8 |
| Cefotaxime 30µg (disc) | 22 | 22 | 22 | 20 |
| Ceftazidime 10µg (disc) | n.d. | n.d. | n.d. | 10-12 |
| Ceftriaxone 30µg (disc) | 20 | 22 | 20 | 18 |
| Chloramphenicol 30µg (disc) | 26 | 28-30 | 28-30 | 28 |
| Ciprofloxacin 5µg (disc) | n.d. | n.d. | n.d. | 26-28 |
| Clindamycin 10µg (disc) | 0 | 8-10 | 0 | 0 |
| Colistin 10µg (disc) | 0 | 0 | 0 | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | n.d. | n.d. | 0 |
| Doxycycline 30µg (disc) | 12 | 12 | 16 | n.d. |
| Erythromycin 15µg (disc) | 0 | 0 | 0 | 0 |
| Fosfomycin 50µg (disc) | 36-38 | 34-36 | 34-36 | 34 |
| Gentamicin 10µg (disc) | 20 | 20 | 22 | n.d. |
| Gentamicin 30µg (disc) | n.d. | n.d. | n.d. | 22 |
| Imipenem 10µg (disc) | 40 | 42 | 40 | 38 |
| Kanamycin 30µg (disc) | 20 | 20 | 22 | 22-24 |
| Levofloxacin 5µg (disc) | n.d. | n.d. | n.d. | 32 |
| Lincomycin 15µg (disc) | 0 | 0 | 0 | n.d. |
| Linezolid 10µg (disc) | 34 | 36 | 38-40 | 38 |
| Meropenem 10µg (disc) | n.d. | n.d. | n.d. | 28 |
| Mezlocillin 30µg (disc) | 16-18 | 16 | 18 | n.d. |
| Moxifloxacin 5µg (disc) | 34 | 32-34 | 34 | 36 |
| Neomycin 30µg (disc) | 18 | 18 | 20 | n.d. |
| Nitrofurantoin 100µg (disc) | 24 | 24 | 26 | 24-26 |
| Norfloxacin 10µg (disc) | 24 | 22-24 | 24 | n.d. |
| Nystatin 100Unit | 0 | 0 | 0 | n.d. |
| Ofloxacin 5µg (disc) | 26-28 | 30 | 30 | 30 |
| Oxacillin 5µg (disc) | 26 | 26 | 26-28 | 22 |
| Penicillin G 6µg (disc) | 12 | 12 | 14 | 10 |
| Pipemidic acid 20µg (disc) | 10 | 8 | 8 | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 24 | 24 | 26 | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | n.d. | n.d. | 24-26 |
| Polymyxin B 300Unit | 8 | 6 | 8 | 6 |
| Quinupristin/Dalfopristin 15µg (disc) | 30 | 30 | 30-32 | 32 |
| Rifampicin 5µg (disc) | n.d. | n.d. | n.d. | 40 |
| Teicoplanin 30µg (disc) | 20 | 20 | 18-20 | 20 |
| Tetracycline 30µg (disc) | 6 | 6 | 8 | 6 |
| Ticarcillin 75µg (disc) | 22 | 22 | 20-22 | 20 |
| Tigecycline 15µg (disc) | n.d. | n.d. | n.d. | 24 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | n.d. | n.d. | 0 |
| Vancomycin 30µg (disc) | 20 | 20 | 20-22 | 20 |
| 18923 | Observationnot MRSA |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68375 | 16899 ChEBI | D-mannitol | + | fermentation | from API ID32STA |
| 68375 | 16024 ChEBI | D-mannose | + | fermentation | from API ID32STA |
| 68375 | 16988 ChEBI | D-ribose | - | fermentation | from API ID32STA |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68375 | 59640 ChEBI | N-acetylglucosamine | + | fermentation | from API ID32STA |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68375 | 16634 ChEBI | raffinose | - | fermentation | from API ID32STA |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68375 | 27082 ChEBI | trehalose | + | fermentation | from API ID32STA |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 18923 | 161680 | Aztreonam | 30 µg (disc) | from Antibiotic test | |
| 18923 | 37943 | Colistin | 10 µg (disc) | from Antibiotic test | |
| 18923 | 37943 | Colistin sulphate | 10 µg (disc) | from Antibiotic test | |
| 18923 | 48923 | Erythromycin | 15 µg (disc) | from Antibiotic test | |
| 18923 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 18923 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 18923 | Trimethoprim-sulfamethoxazole (1:19) | 10 µg (disc) | from Antibiotic test |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 18923 | catalase | + | 1.11.1.6 | |
| 18923 | cytochrome-c oxidase | - | 1.9.3.1 | |
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| @ref | URE | ADH (Arg) | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | Reduction of nitrateNIT | Acetoin production (Voges Proskauer test)VP | beta GAL | L-arginine arylamidaseArgA | PAL | Pyrrolidonyl arylamidasePyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18923 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | + | - | + | + | + | - | - | |
| 18923 | + | - | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | + | + | + | + | - | - | |
| 18923 | + | - | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | - | + | + | + | - | - | |
| 18923 | - | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | +/- | + | + | + | - | - | |
| 63395 | - | + | - | - | + | + | + | + | + | + | + | - | - | - | + | - | - | - | + | - | - | + | + | + | - | - |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Rational Engineering of a Brevinin-2 Peptide: Decoupling Potency from Toxicity Through C-Terminal Truncation and N-Terminal Chiral Substitution | Yao A, Zhang Z, Song Z, Yuan Y, Chen X, Ma C, Chen T, Shaw C, Zhou M, Wang L. | Antibiotics (Basel) | 2025 | | ||
| Emulgel with Origanum vulgare L. Oil: A New Therapeutic Proposal in Case of Dermal Bacterial Infections. | Ganea M, Pelea DC, Groza FM, Gligor O, Vicas LG, Zdrinca M, Lestyan AM, Lestyan M, Venter ID, Ganea MF, Maghiar L, Ghitea TC, Moisa C. | Pharmaceuticals (Basel) | 10.3390/ph18111768 | 2025 | | |
| Anti-Staphylococcus aureus Activity of Volatile Phytochemicals and Their Combinations with Conventional Antibiotics Against Methicillin-Susceptible S. aureus (MSSA) and Methicillin-Resistant S. aureus (MRSA) Strains. | Nikolic I, Aleksic Sabo V, Gavric D, Knezevic P. | Antibiotics (Basel) | 10.3390/antibiotics13111030 | 2024 | | |
| The antimicrobial peptide Temporin-L induces vesicle formation and reduces the virulence in S. aureus. | Cane C, Gallucci N, Amoresano A, Fontanarosa C, Paduano L, De Gregorio E, Duilio A, Di Somma A. | Biochem Biophys Rep | 10.1016/j.bbrep.2024.101808 | 2024 | | |
| Phytotherapeutic potential against MRSA: mechanisms, synergy, and therapeutic prospects. | He Q, Meneely J, Grant IR, Chin J, Fanning S, Situ C. | Chin Med | 10.1186/s13020-024-00960-8 | 2024 | | |
| Butyrate Enhances Antimicrobial Defence in Chicken Macrophages Through Reactive Oxygen Species Generation and Autophagy Activation. | Adams JRG, Anjum FR, Mehat JW, La Ragione RM, Behboudi S. | Cells | 10.3390/cells14211742 | 2025 | | |
| A cross-sectional molecular epidemiological study of biofilm-producing methicillin-resistant Staphylococcus aureus. | Alharbi NK, Elmanakhly AR, Alhomrani M, Alamri AS, Mosbah RA, AbdElrahman M, El-Tarabili RM, Alshehri F, Bendary MM. | Medicine (Baltimore) | 10.1097/md.0000000000043346 | 2025 | | |
| Modification and Synergistic Studies of a Novel Frog Antimicrobial Peptide against Pseudomonas aeruginosa Biofilms. | Liu X, Shi D, Cheng S, Chen X, Ma C, Jiang Y, Wang T, Chen T, Shaw C, Wang L, Zhou M. | Antibiotics (Basel) | 10.3390/antibiotics13070574 | 2024 | | |
| A frog-derived antimicrobial peptide as a potential anti-biofilm agent in combating Staphylococcus aureus skin infection. | Fei F, Wang T, Jiang Y, Chen X, Ma C, Zhou M, Wu Q, Cao P, Duan J, Chen T, Burrows JF, Wang L. | J Cell Mol Med | 10.1111/jcmm.17785 | 2023 | | |
| Biotechnology | Validation of the Peel Plate Staphylococcus Aureus (SA) Test for Enumeration of S. aureus in Selected Foods and Non-Cultured Dairy Products: AOAC Performance Tested MethodSM 082401. | Salter RS, Durbin GW, Li S, Gilbert M, Crowley ES, Deterding A, Bastin B. | J AOAC Int | 10.1093/jaoacint/qsae083 | 2025 | |
| Resistance of Pseudomonas aeruginosa and Staphylococcus aureus to the airway epithelium oxidative response assessed by a cell-free in vitro assay. | Petithomme-Nanrocki M, Nicolau-Guillaumet N, Borie N, Haudrechy A, Renault JH, Moussalih S, Muggeo A, Guillard T. | PLoS One | 10.1371/journal.pone.0306259 | 2024 | | |
| Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms. | Padalino G, Duggan K, Mur LAJ, Maillard JY, Brancale A, Hoffmann KF. | Microbiologyopen | 10.1002/mbo3.70011 | 2024 | | |
| Biotechnology | Guardians of resistance and virulence: detection of mec, femA, Van, pvl, hlg and spa genes in methicillin and vancomycin-resistant Staphylococcus aureus from clinical and food samples in Southwestern Nigeria. | Adeyemi FM, Oyedara OO, Yusuf-Omoloye NA, Ajigbewu OH, Ndaji OL, Adegbite-Badmus MK, Olumakinde TS, Oluokun TE. | BMC Microbiol | 10.1186/s12866-024-03660-3 | 2024 | |
| Progressive Design of a Ranatuerin-2 Peptide from Amolops wuyiensis: Enhancement of Bioactivity and In Vivo Efficacy. | Yao A, Liu T, Cai Y, Zhou S, Chen X, Zhou M, Ma C, Chen T, Shaw C, Wang L. | Antibiotics (Basel) | 10.3390/antibiotics13010005 | 2023 | | |
| Serendipitous Hinge Modulation Hypothetically Reprograms Caerin 1.1-LC Antibacterial Mechanism and Gram-Negative Selectivity. | Sun Z, Zhao R, Zhang Y, Ma X, Jiang Y, Wang T, Chen X, Ma C, Chen T, Shaw C, Zhou M, Wang L. | Pharmaceutics | 10.3390/pharmaceutics17111500 | 2025 | | |
| A promising antibiotic candidate, brevinin-1 analogue 5R, against drug-resistant bacteria, with insights into its membrane-targeting mechanism. | Zou W, Sun R, Yao A, Zhou M, Chen X, Ma C, Wang T, Jiang Y, Chen T, Shaw C, Wang L. | Comput Struct Biotechnol J | 10.1016/j.csbj.2023.11.031 | 2023 | | |
| Biogenic Metal Transformations from Plectranthus amboinicus: Complexes, Nanoparticles, and Therapeutic Applications. | Mohsen EMA, Saeed AAM, Bin Yahia AA. | Int J Nanomedicine | 10.2147/ijn.s538209 | 2025 | | |
| Genetics | Characterizing arginine, ornithine, and putrescine pathways in enteric pathobionts. | Lillie IM, Booth CE, Horvath AE, Mondragon M, Engevik MA, Horvath TD. | Microbiologyopen | 10.1002/mbo3.1408 | 2024 | |
| Hemostatic Antimicrobial Hydrogels Based on Silicon, Iron, Zinc, and Boron Glycerolates for Wound Healing Applications. | Khonina T, Alekseenko S, Shadrina E, Ganebnykh I, Mekhaev A, Larionov L, Dobrinskaya M, Izmozherova N, Antropova I, Karabanalov M, Kokhan M, Evstigneeva N, Chupakhin O. | Gels | 10.3390/gels10120795 | 2024 | | |
| Generation of truncated derivatives through in silico enzymatic digest of peptide GV30 target MRSA both in vitro and in vivo. | Ma Y, Yao A, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. | Comput Struct Biotechnol J | 10.1016/j.csbj.2021.08.039 | 2021 | | |
| Enhancement of Antimicrobial Function by L/D-Lysine Substitution on a Novel Broad-Spectrum Antimicrobial Peptide, Phylloseptin-TO2: A Structure-Related Activity Research Study. | Yin W, Yao J, Leng X, Ma C, Chen X, Jiang Y, Wang T, Chen T, Shaw C, Zhou M, Wang L. | Pharmaceutics | 10.3390/pharmaceutics16081098 | 2024 | | |
| Antimicrobial Resistance of Staphylococcus aureus Isolated between 2017 and 2022 from Infections at a Tertiary Care Hospital in Romania. | Talapan D, Sandu AM, Rafila A. | Antibiotics (Basel) | 10.3390/antibiotics12060974 | 2023 | | |
| Structural and functional analyses of nematode-derived antimicrobial peptides support the occurrence of direct mechanisms of worm-microbiota interactions. | Rooney J, Rivera-de-Torre E, Li R, Mclean K, Price DRG, Nisbet AJ, Laustsen AH, Jenkins TP, Hofmann A, Bakshi S, Zarkan A, Cantacessi C. | Comput Struct Biotechnol J | 10.1016/j.csbj.2024.04.019 | 2024 | | |
| Exploring the active core of a novel antimicrobial peptide, palustrin-2LTb, from the Kuatun frog, Hylarana latouchii, using a bioinformatics-directed approach. | Zou W, Zhang Y, Zhou M, Chen X, Ma C, Wang T, Jiang Y, Chen T, Shaw C, Wang L. | Comput Struct Biotechnol J | 10.1016/j.csbj.2022.11.016 | 2022 | | |
| Discovery and analysis of a novel antimicrobial peptide B1AW from the skin secretion of Amolops wuyiensis and improving the membrane-binding affinity through the construction of the lysine-introduced analogue. | Qin H, Zuo W, Ge L, Siu SWI, Wang L, Chen X, Ma C, Chen T, Zhou M, Cao Z, Kwok HF. | Comput Struct Biotechnol J | 10.1016/j.csbj.2023.05.006 | 2023 | | |
| A Designed Analog of an Antimicrobial Peptide, Crabrolin, Exhibits Enhanced Anti-Proliferative and In Vivo Antimicrobial Activity. | Yao A, Ma Y, Sun R, Zou W, Chen X, Zhou M, Ma C, Chen T, Shaw C, Wang L. | Int J Mol Sci | 10.3390/ijms241914472 | 2023 | | |
| Engineering of antimicrobial peptide Brevinin-1pl: arginine, lysine, and histidine substitutions enhance antimicrobial-anticancer efficacy with reduced cytotoxicity | Wang J, Zeng F, Chen X, Wang T, Wang L, Zhou M, Jiang Y, Chen T, Fang Y, Zhang J. | Front Chem | 2025 | | ||
| Beneficial modulation of the gut microbiome by leachates of Penicillium purpurogenum in the presence of clays: A model for the preparation and efficacy of historical Lemnian Earth. | Milling S, Ijaz UZ, Venieri D, Christidis GE, Rattray NJW, Gounaki I, Andrusaite A, Hareendran A, Knapp CW, Jones AX, Photos-Jones E. | PLoS One | 10.1371/journal.pone.0313090 | 2024 | | |
| In Vitro Evaluation of Rosemary Essential Oil: GC-MS Profiling, Antibacterial Synergy, and Biofilm Inhibition. | Kabotso DEK, Neglo D, Gaba SE, Danyo EK, Dayie AD, Asantewaa AA, Kotey FCN, Dayie NTKD. | Pharmaceuticals (Basel) | 10.3390/ph17121653 | 2024 | | |
| An Effective Modification Strategy to Build Multifunctional Peptides Based on a Trypsin Inhibitory Peptide of the Kunitz Family. | Wang Y, Shi D, Zou W, Jiang Y, Wang T, Chen X, Ma C, Li W, Chen T, Burrows JF, Wang L, Zhou M. | Pharmaceutics | 10.3390/pharmaceutics16050597 | 2024 | | |
| Community-acquired antimicrobial resistance among Syrian refugees and the local population in Türkiye. | Yildiz SS, Hekimoglu CH, Sucakli MB, Bakkaloglu Z, Cevik YN, Unaldi O, Arslanturk H, Zikusooka M, Kecik M, Nellums L, Elci OC. | Eur J Public Health | 10.1093/eurpub/ckad119 | 2023 | | |
| Bioevaluation and Targeted Modification of Temporin-FL From the Skin Secretion of Dark-Spotted Frog (Pelophylax nigromaculatus). | Wang W, Yang W, Du S, Xi X, Ma C, Wang L, Zhou M, Chen T. | Front Mol Biosci | 10.3389/fmolb.2021.707013 | 2021 | | |
| Genetics | Multilocus sequence type analysis of coagulase-negative staphylococci from the neonatal intensive care unit of a teaching hospital in Ghana. | Afeke I, Adu-Amankwaah J, Jamfaru I, Hamid AM, Orish VN, Agbodzi B, Amegan-Aho KH, Ankrah LM, Mbroh HK, Mensah GL, Ablordey AS. | Pan Afr Med J | 10.11604/pamj.2025.51.59.45565 | 2025 | |
| Senegalin-2: A Novel Hexadecapeptide from Kassina senegalensis with Antibacterial and Muscle Relaxant Activities, and Its Derivative Senegalin-2BK as a Bradykinin Antagonist. | Lu Y, Zhu Y, Ma C, Wang L, Zhou M, Chen T, Ma X, Zhang X, Fan Z. | Biomolecules | 10.3390/biom15010030 | 2024 | | |
| Antibiofilm Activity of Azadirachta indica and Catharanthus roseus and Their Synergistic Effects in Combination with Antimicrobial Agents against Fluconazole-Resistant Candida albicans Strains and MRSA. | Neglo D, Adzaho F, Agbo IA, Arthur R, Sedohia D, Tettey CO, Waikhom SD. | Evid Based Complement Alternat Med | 10.1155/2022/9373524 | 2022 | | |
| Pathogenicity | Modification Strategy of D-leucine Residue Addition on a Novel Peptide from Odorrana schmackeri, with Enhanced Bioactivity and In Vivo Efficacy. | Yao A, Ma Y, Chen X, Zhou M, Xi X, Ma C, Ren S, Chen T, Shaw C, Wang L. | Toxins (Basel) | 10.3390/toxins13090611 | 2021 | |
| Isolation and Identification of Flavanone Derivative Eriodictyol from the Methanol Extract of Afzelia africana Bark and Its Antimicrobial and Antioxidant Activities. | Vigbedor BY, Osei Akoto C, Neglo D. | Evid Based Complement Alternat Med | 10.1155/2023/9345047 | 2023 | | |
| Discovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria. | Liao F, Ye Z, Cheng J, Zhu J, Chen X, Zhou X, Wang T, Jiang Y, Ma C, Zhou M, Chen T, Shaw C, Wang L. | Sci Rep | 10.1038/s41598-024-67777-1 | 2024 | | |
| Evaluation of the Modulatory Effect of Annona muricata Extracts on the Activity of Some Selected Antibiotics against Biofilm-Forming MRSA. | Neglo D, Tettey CO, Essuman EK, Amenu JD, Mills-Robertson FC, Sedohia D, Boakye AA, Abaye DA. | Evid Based Complement Alternat Med | 10.1155/2021/9342110 | 2021 | | |
| Nanoarchitectonics of Bactericidal Coatings Based on CaCO3-Nanosilver Hybrids. | Ferreira AM, Vikulina AS, Bowker L, Hunt JA, Loughlin M, Puddu V, Volodkin D. | ACS Appl Bio Mater | 10.1021/acsabm.3c01228 | 2024 | | |
| Broad-Spectrum Antimicrobial Activity and Improved Stability of a D-Amino Acid Enantiomer of DMPC-10A, the Designed Derivative of Dermaseptin Truncates. | Zai Y, Ying Y, Ye Z, Zhou M, Ma C, Shi Z, Chen X, Xi X, Chen T, Wang L. | Antibiotics (Basel) | 10.3390/antibiotics9090627 | 2020 | | |
| Enzymology | A Novel Antimicrobial Peptide, Dermaseptin-SS1, with Anti-Proliferative Activity, Isolated from the Skin Secretion of Phyllomedusa tarsius. | Ma X, Chen Y, Shu A, Jiang Y, Chen X, Ma C, Zhou M, Wang T, Chen T, Shaw C, Wang L. | Molecules | 10.3390/molecules28186558 | 2023 | |
| Glycosides of Nadifloxacin-Synthesis and Antibacterial Activities against Methicillin-Resistant Staphylococcus aureus. | Hutchins M, Bovill RA, Stephens PJ, Brazier JA, Osborn HMI. | Molecules | 10.3390/molecules27051504 | 2022 | | |
| Pathogenicity | Extracts of Sida cordifolia contain polysaccharides possessing immunomodulatory activity and rosmarinic acid compounds with antibacterial activity. | Iqbal H, Wright CL, Jones S, da Silva GR, McKillen J, Gilmore BF, Kavanagh O, Green BD. | BMC Complement Med Ther | 10.1186/s12906-022-03502-7 | 2022 | |
| A Time-Kill Assay Study on the Synergistic Bactericidal Activity of Pomegranate Rind Extract and Zn (II) against Methicillin-Resistant Staphylococcus aureus (MRSA), Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa. | Alrashidi A, Jafar M, Higgins N, Mulligan C, Varricchio C, Moseley R, Celiksoy V, Houston DMJ, Heard CM. | Biomolecules | 10.3390/biom11121889 | 2021 | | |
| Advances in silver nanoparticles: a comprehensive review on their potential as antimicrobial agents and their mechanisms of action elucidated by proteomics. | Rodrigues AS, Batista JGS, Rodrigues MAV, Thipe VC, Minarini LAR, Lopes PS, Lugao AB. | Front Microbiol | 10.3389/fmicb.2024.1440065 | 2024 | | |
| Discovery of a Novel Antimicrobial Peptide, Temporin-PKE, from the Skin Secretion of Pelophylax kl. esculentus, and Evaluation of Its Structure-Activity Relationships. | Lin Y, Jiang Y, Zhao Z, Lu Y, Xi X, Ma C, Chen X, Zhou M, Chen T, Shaw C, Wang L. | Biomolecules | 10.3390/biom12060759 | 2022 | | |
| Multi-Drug Resistant Bacteria as Aetiological Factors of Infections in a Tertiary Multidisciplinary Hospital in Poland. | Poletajew S, Pawlik K, Bonder-Nowicka A, Pakuszewski A, Nyk L, Kryst P. | Antibiotics (Basel) | 10.3390/antibiotics10101232 | 2021 | | |
| Antibacterial Properties of Biodegradable Silver Nanoparticle Foils Based on Various Strains of Pathogenic Bacteria Isolated from the Oral Cavity of Cats, Dogs and Horses. | Rutkowski M, Krzeminska-Fiedorowicz L, Khachatryan G, Kabacinska J, Tischner M, Suder A, Kulik K, Lenart-Boron A. | Materials (Basel) | 10.3390/ma15031269 | 2022 | | |
| The Antibacterial Activity of Human Amniotic Membrane against Multidrug-Resistant Bacteria Associated with Urinary Tract Infections: New Insights from Normal and Cancerous Urothelial Models. | Ramuta TZ, Tratnjek L, Janev A, Seme K, Starcic Erjavec M, Kreft ME, Kreft ME. | Biomedicines | 10.3390/biomedicines9020218 | 2021 | | |
| Discovery, development and optimisation of a novel frog antimicrobial peptide with combined mode of action against drug-resistant bacteria. | Wang J, Hu J, Pu W, Chen X, Ma C, Jiang Y, Wang T, Chen T, Shaw C, Zhou M, Wang L. | Comput Struct Biotechnol J | 10.1016/j.csbj.2024.09.006 | 2024 | | |
| Effects of Different Inhalation Therapy on Ventilator-Associated Pneumonia in Ventilated COVID-19 Patients: A Randomized Controlled Trial. | Delic N, Matetic A, Domjanovic J, Kljakovic-Gaspic T, Saric L, Ilic D, Dosenovic S, Domazet J, Kovac R, Runjic F, Stipic SS, Duplancic B. | Microorganisms | 10.3390/microorganisms10061118 | 2022 | | |
| Antimicrobial profile of coagulase-negative staphylococcus isolates from categories of individuals at a neonatal intensive care unit of a tertiary hospital, Ghana. | Afeke I, Amegan-Aho KH, Adu-Amankwaah J, Orish VN, Mensah GL, Mbroh HK, Jamfaru I, Hamid AM, Ankrah LM, Korbuvi J, Ablordey A. | Pan Afr Med J | 10.11604/pamj.2023.44.92.37229 | 2023 | | |
| Antimicrobial susceptibility profiles of clinically important bacterial pathogens at the Kamuzu Central Hospital in Lilongwe, Malawi. | Choonara FE, Haldorsen BC, Ndhlovu I, Saulosi O, Maida T, Lampiao F, Simonsen GS, Essack SY, Sundsfjord A. | Malawi Med J | 10.4314/mmj.v34i1.3 | 2022 | | |
| Structural and Functional Characterization of a Novel Recombinant Antimicrobial Peptide from Hermetia illucens. | Di Somma A, Moretta A, Cane C, Scieuzo C, Salvia R, Falabella P, Duilio A. | Curr Issues Mol Biol | 10.3390/cimb44010001 | 2021 | | |
| Methicillin-Resistant Staphylococcus aureus Harboring mecC Still Eludes Us in East London, United Kingdom. | Ciesielczuk H, Xenophontos M, Lambourne J. | J Clin Microbiol | 10.1128/jcm.00020-19 | 2019 | | |
| Exploration of the Structure-Function Relationships of a Novel Frog Skin Secretion-Derived Bioactive Peptide, t-DPH1, through Use of Rational Design, Cationicity Enhancement and In Vitro Studies. | Qin H, Fang H, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. | Antibiotics (Basel) | 10.3390/antibiotics10121529 | 2021 | | |
| Multiple Antimicrobial Resistance in Methicillin-Resistant Staphylococcus sciuri Group Isolates from Wild Ungulates in Spain. | Rey Perez J, Zalama Rosa L, Garcia Sanchez A, Hermoso de Mendoza Salcedo J, Alonso Rodriguez JM, Cerrato Horrillo R, Zurita SG, Gil Molino M. | Antibiotics (Basel) | 10.3390/antibiotics10080920 | 2021 | | |
| Study on the Structure-Activity Relationship of an Antimicrobial Peptide, Brevinin-2GUb, from the Skin Secretion of Hylarana guentheri. | Lin Y, Liu S, Xi X, Ma C, Wang L, Chen X, Shi Z, Chen T, Shaw C, Zhou M. | Antibiotics (Basel) | 10.3390/antibiotics10080895 | 2021 | | |
| Conjugation of a Cationic Cell-Penetrating Peptide with a Novel Kunitzin-like Trypsin Inhibitor: New Insights for Enhancement of Peptide Bioactivities. | Yao J, Yin W, Chen Y, Chen X, Jiang Y, Wang T, Ma C, Zhou M, Chen T, Shaw C, Wang L. | Pharmaceutics | 10.3390/pharmaceutics14091805 | 2022 | | |
| SCMRSA: a New Approach for Identifying and Analyzing Anti-MRSA Peptides Using Estimated Propensity Scores of Dipeptides. | Charoenkwan P, Kanthawong S, Schaduangrat N, Li' P, Moni MA, Shoombuatong W. | ACS Omega | 10.1021/acsomega.2c04305 | 2022 | | |
| Kassporin-KS1: A Novel Pentadecapeptide from the Skin Secretion of Kassina senegalensis: Studies on the Structure-Activity Relationships of Site-Specific "Glycine-Lysine" Motif Insertions. | Lu Y, Zou W, Wang L, Xi X, Ma C, Chen X, Chen T, Shaw C, Zhang X, Zhou M. | Antibiotics (Basel) | 10.3390/antibiotics11020243 | 2022 | | |
| Impact of growth media and pressure on the diversity and antimicrobial activity of isolates from two species of hexactinellid sponge. | Koch MJ, Hesketh-Best PJ, Smerdon G, Warburton PJ, Howell K, Upton M. | Microbiology (Reading) | 10.1099/mic.0.001123 | 2021 | | |
| How similar is the antibacterial activity of silver nanoparticles coated with different capping agents? | Ferreira AM, Vikulina A, Loughlin M, Volodkin D. | RSC Adv | 10.1039/d3ra00917c | 2023 | | |
| A Novel Dermaseptin Isolated from the Skin Secretion of Phyllomedusa tarsius and Its Cationicity-Enhanced Analogue Exhibiting Effective Antimicrobial and Anti-Proliferative Activities. | Li M, Xi X, Ma C, Chen X, Zhou M, Burrows JF, Chen T, Wang L. | Biomolecules | 10.3390/biom9100628 | 2019 | | |
| Multidrug-Resistant Bacteria Isolated from Blood Culture Samples in a Moroccan Tertiary Hospital: True Bacteremia or Contamination? | Nachate S, Rouhi S, Ouassif H, Bennani H, Hachimi A, Mouaffak Y, Younous S, Bennaoui F, El Idrissi Slitine N, Maoulainine FMR, Lamrani Hanchi A, Soraa N. | Infect Drug Resist | 10.2147/idr.s373065 | 2022 | | |
| Protein profile of the Escherichia coli strain, BW25113, exposed to two novel iron-halide compounds: Fe(Hampy)2Cl4 and Fe(Hampy)2Br4. | Abedin N, Wagner S, Khalkar YS, Johnson Z, Egbowon BF, Hargreaves AJ, Fitzpatrick AJ, Miles AK, Dafhnis-Calas F. | Access Microbiol | 10.1099/acmi.0.000783.v4 | 2025 | | |
| Clonality and Persistence of Multiresistant Methicillin-Resistant Coagulase-Negative Staphylococci Isolated from the Staff of a University Veterinary Hospital. | Rey J, Gil M, de Mendoza JH, Garcia A, Gaitskell-Phillips G, Bastidas-Caldes C, Zalama L. | Antibiotics (Basel) | 10.3390/antibiotics11060811 | 2022 | | |
| Spontaneously Occurring Small-Colony Variants of Staphylococcus aureus Show Enhanced Clearance by THP-1 Macrophages. | Stoneham SM, Cantillon DM, Waddell SJ, Llewelyn MJ. | Front Microbiol | 10.3389/fmicb.2020.01300 | 2020 | | |
| Antiviral Efficacy of Metal and Metal Oxide Nanoparticles against the Porcine Reproductive and Respiratory Syndrome Virus. | Graham SP, Cheong YK, Furniss S, Nixon E, Smith JA, Yang X, Fruengel R, Hussain S, Tchorzewska MA, La Ragione RM, Ren G. | Nanomaterials (Basel) | 10.3390/nano11082120 | 2021 | | |
| Rapid culture-independent loop-mediated isothermal amplification detection of antimicrobial resistance markers from environmental water samples. | Hassan MM, van Vliet AHM, Higgins O, Burke LP, Chueiri A, O'Connor L, Morris D, Smith TJ, La Ragione RM. | Microb Biotechnol | 10.1111/1751-7915.14227 | 2023 | | |
| In Vitro Efficacy of Antibiotics Released from Calcium Sulfate Bone Void Filler Beads. | Laycock PA, Cooper JJ, Howlin RP, Delury C, Aiken S, Stoodley P. | Materials (Basel) | 10.3390/ma11112265 | 2018 | | |
| Ranacyclin-NF, a Novel Bowman-Birk Type Protease Inhibitor from the Skin Secretion of the East Asian Frog, Pelophylax nigromaculatus. | Wang T, Jiang Y, Chen X, Wang L, Ma C, Xi X, Zhang Y, Chen T, Shaw C, Zhou M. | Biology (Basel) | 10.3390/biology9070149 | 2020 | | |
| A Combination of Novel Nucleic Acid Cross-Linking Dye and Recombinase-Aided Amplification for the Rapid Detection of Viable Salmonella in Milk. | Feng X, Zhou D, Gan B, Xie G, Xu H. | Foods | 10.3390/foods11152375 | 2022 | | |
| Genetics | Identification of an antibacterial protein by functional screening of a human oral metagenomic library. | Arivaradarajan P, Warburton PJ, Paramasamy G, Nair SP, Allan E, Mullany P. | FEMS Microbiol Lett | 10.1093/femsle/fnv142 | 2015 | |
| Modification Targeting the "Rana Box" Motif of a Novel Nigrocin Peptide From Hylarana latouchii Enhances and Broadens Its Potency Against Multiple Bacteria. | Bao K, Yuan W, Ma C, Yu X, Wang L, Hong M, Xi X, Zhou M, Chen T. | Front Microbiol | 10.3389/fmicb.2018.02846 | 2018 | | |
| Phylogeny | Marine Actinobacteria: Screening for Predation Leads to the Discovery of Potential New Drugs against Multidrug-Resistant Bacteria. | Ibrahimi M, Korichi W, Hafidi M, Lemee L, Ouhdouch Y, Loqman S. | Antibiotics (Basel) | 10.3390/antibiotics9020091 | 2020 | |
| Enzymology | Evaluating the Bioactivity of a Novel Antimicrobial and Anticancer Peptide, Dermaseptin-PS4(Der-PS4), from the Skin Secretion of Phyllomedusa sauvagii. | Chen D, Zhou X, Chen X, Huang L, Xi X, Ma C, Zhou M, Wang L, Chen T. | Molecules | 10.3390/molecules24162974 | 2019 | |
| Pathogenicity | Antibacterial action mechanisms and mode of trypsin inhibitors: a systematic review. | de Souza Nascimento AM, de Oliveira Segundo VH, Felipe Camelo Aguiar AJ, Piuvezam G, Souza Passos T, Florentino da Silva Chaves Damasceno KSFDS, de Araujo Morais AH. | J Enzyme Inhib Med Chem | 10.1080/14756366.2022.2039918 | 2022 | |
| Antimicrobial activity of novel nanostructured Cu-SiO2 coatings prepared by chemical vapour deposition against hospital related pathogens. | Varghese S, Elfakhri SO, Sheel DW, Sheel P, Bolton FJ, Foster HA. | AMB Express | 10.1186/2191-0855-3-53 | 2013 | | |
| Synthesis and antimicrobial effects of highly dispersed, cellulose-stabilized silver/cellulose nanocomposites. | Alahmadi NS, Betts JW, Heinze T, Kelly SM, Koschella A, Wadhawan JD. | RSC Adv | 10.1039/c7ra12280b | 2018 | | |
| Brevinin-2GHk from Sylvirana guentheri and the Design of Truncated Analogs Exhibiting the Enhancement of Antimicrobial Activity. | Chen G, Miao Y, Ma C, Zhou M, Shi Z, Chen X, Burrows JF, Xi X, Chen T, Wang L. | Antibiotics (Basel) | 10.3390/antibiotics9020085 | 2020 | | |
| Design, Synthesis and Microbiological Evaluation of Novel Compounds as Potential Staphylococcus aureus Phenylalanine tRNA Synthetase Inhibitors. | Elbaramawi SS, Hughes C, Richards J, Gupta A, Ibrahim SM, Lashine EM, El-Sadek ME, O'Neill AJ, Wootton M, Bullard JM, Simons C. | Egypt J Chem | 10.21608/ejchem.2018.4070.1357 | 2018 | | |
| Pathogenicity | A mecC allotype, mecC3, in the CoNS Staphylococcus caeli, encoded within a variant SCCmecC. | MacFadyen AC, Harrison EM, Drigo I, Parkhill J, Holmes MA, Paterson GK. | J Antimicrob Chemother | 10.1093/jac/dky502 | 2019 | |
| Metabolism | Identification and Target-Modification of SL-BBI: A Novel Bowman-Birk Type Trypsin Inhibitor from Sylvirana latouchii. | Chen X, Chen D, Huang L, Chen X, Zhou M, Xi X, Ma C, Chen T, Wang L. | Biomolecules | 10.3390/biom10091254 | 2020 | |
| Enzymology | Prevalence and properties of mecC methicillin-resistant Staphylococcus aureus (MRSA) in bovine bulk tank milk in Great Britain. | Paterson GK, Morgan FJ, Harrison EM, Peacock SJ, Parkhill J, Zadoks RN, Holmes MA. | J Antimicrob Chemother | 10.1093/jac/dkt417 | 2014 | |
| Aggregation and Its Influence on the Bioactivities of a Novel Antimicrobial Peptide, Temporin-PF, and Its Analogues. | Zai Y, Xi X, Ye Z, Ma C, Zhou M, Chen X, Siu SWI, Chen T, Wang L, Kwok HF. | Int J Mol Sci | 10.3390/ijms22094509 | 2021 | | |
| Metabolism | Evaluating the Bioactivity of a Novel Broad-Spectrum Antimicrobial Peptide Brevinin-1GHa from the Frog Skin Secretion of Hylarana guentheri and Its Analogues. | Chen Q, Cheng P, Ma C, Xi X, Wang L, Zhou M, Bian H, Chen T. | Toxins (Basel) | 10.3390/toxins10100413 | 2018 | |
| Pathogenicity | PSN-PC: A Novel Antimicrobial and Anti-Biofilm Peptide from the Skin Secretion of Phyllomedusa-camba with Cytotoxicity on Human Lung Cancer Cell. | Wu X, Pan J, Wu Y, Xi X, Ma C, Wang L, Zhou M, Chen T. | Molecules | 10.3390/molecules22111896 | 2017 | |
| AI-based mobile application to fight antibiotic resistance. | Pascucci M, Royer G, Adamek J, Asmar MA, Aristizabal D, Blanche L, Bezzarga A, Boniface-Chang G, Brunner A, Curel C, Dulac-Arnold G, Fakhri RM, Malou N, Nordon C, Runge V, Samson F, Sebastian E, Soukieh D, Vert JP, Ambroise C, Madoui MA. | Nat Commun | 10.1038/s41467-021-21187-3 | 2021 | | |
| Bridging the Gaps: Bole and Terra Sigillata as Artefacts, as Simples and as Antibacterial Clays. | Venieri D, Gounaki I, Christidis GE, Knapp CW, Bouras-Vallianatos P, Photos-Jones E. | Minerals (Basel) | 10.3390/min10040348 | 2020 | | |
| Enzymology | Novel mutations in penicillin-binding protein genes in clinical Staphylococcus aureus isolates that are methicillin resistant on susceptibility testing, but lack the mec gene. | Ba X, Harrison EM, Edwards GF, Holden MT, Larsen AR, Petersen A, Skov RL, Peacock SJ, Parkhill J, Paterson GK, Holmes MA. | J Antimicrob Chemother | 10.1093/jac/dkt418 | 2014 | |
| Enzymology | Dermaseptin-PH: A Novel Peptide with Antimicrobial and Anticancer Activities from the Skin Secretion of the South American Orange-Legged Leaf Frog, Pithecopus (Phyllomedusa) hypochondrialis. | Huang L, Chen D, Wang L, Lin C, Ma C, Xi X, Chen T, Shaw C, Zhou M. | Molecules | 10.3390/molecules22101805 | 2017 | |
| Pathogenicity | Antimicrobial activity of bone cements embedded with organic nanoparticles. | Perni S, Thenault V, Abdo P, Margulis K, Magdassi S, Prokopovich P. | Int J Nanomedicine | 10.2147/ijn.s86440 | 2015 | |
| Metabolism | Discovery of Phylloseptins that Defense against Gram-Positive Bacteria and Inhibit the Proliferation of the Non-Small Cell Lung Cancer Cell Line, from the Skin Secretions of Phyllomedusa Frogs. | Liu J, Wu Q, Li L, Xi X, Wu D, Zhou M, Chen T, Shaw C, Wang L. | Molecules | 10.3390/molecules22091428 | 2017 | |
| Enzymology | Targeted Modification of a Novel Amphibian Antimicrobial Peptide from Phyllomedusa tarsius to Enhance Its Activity against MRSA and Microbial Biofilm. | Gao Y, Wu D, Wang L, Lin C, Ma C, Xi X, Zhou M, Duan J, Bininda-Emonds ORP, Chen T, Shaw C. | Front Microbiol | 10.3389/fmicb.2017.00628 | 2017 | |
| Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad. | Thati V, Shivannavar CT, Gaddad SM. | Indian J Med Res | 10.4103/0971-5916.91001 | 2011 | | |
| Prevalence and Antimicrobial Susceptibility Pattern of Methicillin-resistant Staphylococcus Aureus [MRSA] Isolates at a Tertiary Care Hospital in Mangalore, South India. | Pai V, Rao VI, Rao SP. | J Lab Physicians | 10.4103/0974-2727.72155 | 2010 | | |
| Enzymology | Novel Frog Skin-Derived Peptide Dermaseptin-PP for Lung Cancer Treatment: In vitro/vivo Evaluation and Anti-tumor Mechanisms Study. | Dong Z, Hu H, Yu X, Tan L, Ma C, Xi X, Li L, Wang L, Zhou M, Chen T, Du S, Lu Y. | Front Chem | 10.3389/fchem.2020.00476 | 2020 | |
| Pathogenicity | Brevinin-1GHd: a novel Hylarana guentheri skin secretion-derived Brevinin-1 type peptide with antimicrobial and anticancer therapeutic potential. | Jiang Y, Wu Y, Wang T, Chen X, Zhou M, Ma C, Xi X, Zhang Y, Chen T, Shaw C, Wang L. | Biosci Rep | 10.1042/bsr20200019 | 2020 | |
| Discovery of Novel Caeridins from the Skin Secretion of the Australian White's Tree Frog, Litoria caerulea. | Li L, Wu Q, Wang X, Lu H, Xi X, Zhou M, Watson CJ, Chen T, Wang L. | Int J Genomics | 10.1155/2018/8158453 | 2018 | | |
| An Injectable Hydrogel as Bone Graft Material with Added Antimicrobial Properties. | Tommasi G, Perni S, Prokopovich P. | Tissue Eng Part A | 10.1089/ten.tea.2016.0014 | 2016 | | |
| The rumen microbiome: an underexplored resource for novel antimicrobial discovery. | Oyama LB, Girdwood SE, Cookson AR, Fernandez-Fuentes N, Prive F, Vallin HE, Wilkinson TJ, Golyshin PN, Golyshina OV, Mikut R, Hilpert K, Richards J, Wootton M, Edwards JE, Maresca M, Perrier J, Lundy FT, Luo Y, Zhou M, Hess M, Mantovani HC, Creevey CJ, Huws SA. | NPJ Biofilms Microbiomes | 10.1038/s41522-017-0042-1 | 2017 | | |
| The ecology and bioactivity of some Greco-Roman medicinal minerals: the case of Melos earth pigments. | Knapp CW, Christidis GE, Venieri D, Gounaki I, Gibney-Vamvakari J, Stillings M, Photos-Jones E. | Archaeol Anthropol Sci | 10.1007/s12520-021-01396-z | 2021 | | |
| Identification and Rational Design of a Novel Antibacterial Peptide Dermaseptin-AC from the Skin Secretion of the Red-Eyed Tree Frog Agalychnis callidryas. | Gong Z, Pei X, Ren S, Chen X, Wang L, Ma C, Xi X, Chen T, Shaw C, Zhou M. | Antibiotics (Basel) | 10.3390/antibiotics9050243 | 2020 | | |
| Potent antimicrobial activity of bone cement encapsulating silver nanoparticles capped with oleic acid. | Prokopovich P, Kobrick M, Brousseau E, Perni S. | J Biomed Mater Res B Appl Biomater | 10.1002/jbm.b.33196 | 2015 | | |
| Development of Loop-Mediated Isothermal Amplification Rapid Diagnostic Assays for the Detection of Klebsiella pneumoniae and Carbapenemase Genes in Clinical Samples. | Poirier AC, Kuang D, Siedler BS, Borah K, Mehat JW, Liu J, Tai C, Wang X, van Vliet AHM, Ma W, Jenkins DR, Clark J, La Ragione RM, Qu J, McFadden J. | Front Mol Biosci | 10.3389/fmolb.2021.794961 | 2021 | | |
| Antimicrobial Activity of Human Fetal Membranes: From Biological Function to Clinical Use. | Ramuta TZ, Sket T, Starcic Erjavec M, Kreft ME. | Front Bioeng Biotechnol | 10.3389/fbioe.2021.691522 | 2021 | | |
| Pathogenicity | The Antibacterial Activity of Acetic Acid against Biofilm-Producing Pathogens of Relevance to Burns Patients. | Halstead FD, Rauf M, Moiemen NS, Bamford A, Wearn CM, Fraise AP, Lund PA, Oppenheim BA, Webber MA. | PLoS One | 10.1371/journal.pone.0136190 | 2015 | |
| Pathogenicity | The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Malta. | Gould SW, Cuschieri P, Rollason J, Hilton AC, Easmon S, Fielder MD. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-9-20 | 2010 | |
| Continuous release of gentamicin from gold nanocarriers. | Perni S, Prokopovich P. | RSC Adv | 10.1039/c4ra10023a | 2014 | | |
| A novel hybrid SCCmec-mecC region in Staphylococcus sciuri. | Harrison EM, Paterson GK, Holden MT, Ba X, Rolo J, Morgan FJ, Pichon B, Kearns A, Zadoks RN, Peacock SJ, Parkhill J, Holmes MA. | J Antimicrob Chemother | 10.1093/jac/dkt452 | 2014 | | |
| Removal of Contaminant DNA by Combined UV-EMA Treatment Allows Low Copy Number Detection of Clinically Relevant Bacteria Using Pan-Bacterial Real-Time PCR. | Humphrey B, McLeod N, Turner C, Sutton JM, Dark PM, Warhurst G. | PLoS One | 10.1371/journal.pone.0132954 | 2015 | | |
| Enzymology | Using marker pens on patients: a potential source of cross infection with MRSA. | Tadiparthi S, Shokrollahi K, Juma A, Croall J. | Ann R Coll Surg Engl | 10.1308/003588407x209419 | 2007 | |
| Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. | Garcia-Alvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, Walpole E, Brooks K, Pickard DJ, Teale C, Parkhill J, Bentley SD, Edwards GF, Girvan EK, Kearns AM, Pichon B, Hill RL, Larsen AR, Skov RL, Peacock SJ, Maskell DJ, Holmes MA. | Lancet Infect Dis | 10.1016/s1473-3099(11)70126-8 | 2011 | | |
| Metabolism | A natural plasmid uniquely encodes two biosynthetic pathways creating a potent anti-MRSA antibiotic. | Fukuda D, Haines AS, Song Z, Murphy AC, Hothersall J, Stephens ER, Gurney R, Cox RJ, Crosby J, Willis CL, Simpson TJ, Thomas CM. | PLoS One | 10.1371/journal.pone.0018031 | 2011 | |
| A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections. | Hu Y, Shamaei-Tousi A, Liu Y, Coates A. | PLoS One | 10.1371/journal.pone.0011818 | 2010 | | |
| Greco-Roman mineral (litho)therapeutics and their relationship to their microbiome: The case of the red pigment miltos. | Photos-Jones E, Knapp CW, Venieri D, Christidis GE, Elgy C, Valsami-Jones E, Gounaki I, Andriopoulou NC. | J Archaeol Sci Rep | 10.1016/j.jasrep.2018.07.017 | 2018 | | |
| Enzymology | Virulence Analysis of Bacillus cereus Isolated after Death of Preterm Neonates, Nice, France, 2013. | Lotte R, Herisse AL, Berrouane Y, Lotte L, Casagrande F, Landraud L, Herbin S, Ramarao N, Boyer L, Ruimy R. | Emerg Infect Dis | 10.3201/eid2305.161788 | 2017 | |
| Antibacterial potential of Malaysian ethnomedicinal plants against methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). | Yi Xin L, Hui Min T, Nur Liyana Mohd Zin P, Pulingam T, Nelson Appaturi J, Parumasivam T | Saudi J Biol Sci | 10.1016/j.sjbs.2021.06.036 | 2021 | | |
| Phylogeny | Antibacterial Activities of Echinops kebericho Mesfin Tuber Extracts and Isolation of the Most Active Compound, Dehydrocostus Lactone. | Deyno S, Mtewa AG, Hope D, Bazira J, Makonnen E, Alele PE | Front Pharmacol | 10.3389/fphar.2020.608672 | 2021 | |
| Pathogenicity | Resistance and tolerance to tropodithietic acid, an antimicrobial in aquaculture, is hard to select. | Porsby CH, Webber MA, Nielsen KF, Piddock LJ, Gram L | Antimicrob Agents Chemother | 10.1128/AAC.01222-10 | 2011 | |
| Pathogenicity | Reversing methicillin resistance in MRSA using a bacterial transforming agent. | Carey BE, Dancer SJ | J Antimicrob Chemother | 10.1093/jac/dkl245 | 2006 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive23295.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License